An international study of the effect of Valsartan in hypertrophic cardiomyopathy.
Phase II randomized, placebo-controlled, double blind clinical trial of valsartan for attenuating disease evolution in early sarcomeric HCM - VANISH Phase II randomized, placebo-controlled, double blind clinical trial of valsartan for attenuating di ...